From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Having been a French immersion student since the fourth grade, I always thought I’d had a solid command of the language.

The global bioconjugation market is set to witness a growth rate of ~13% in the next 5 years. Increasing demand for targeted ...

As part of the collaboration, Secarna will leverage its proprietary, AI-empowered OligoCreator® discovery and development platform to identify promising oligonucleotide candidates, applying both ...

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. Click here to read more.

DelveInsight's DNA Synthesis Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Preclinical data presented at the 10th Annual CAR-TCR Summit demonstrated deep depletion of B cells in blood and tissue in humanized mouse models and non-human primates, supporting nomination of ...

"I just liked working with them so much that I joined them," Chen told BioWorld. Today, Chen is co-CEO of WuXi AppTec. The company, which started with a laboratory of 7,000 square feet, has grown into ...

The DNA synthesis inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of cancer diagnoses, growing awareness, the expanding pipeline ...

Although a start-up's recent triumph is seen as a 'DeepSeek moment', domestic players still trail world-beating pharma firms, ...

Fortunately, modern packaging solutions with advanced technologies and smart systems can increase the efficiency of packaging ...